348 related articles for article (PubMed ID: 20615726)
1. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.
Nath DS; Ilias Basha H; Tiriveedhi V; Alur C; Phelan D; Ewald GA; Moazami N; Mohanakumar T
J Heart Lung Transplant; 2010 Nov; 29(11):1277-85. PubMed ID: 20615726
[TBL] [Abstract][Full Text] [Related]
2. A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy.
Nath DS; Tiriveedhi V; Basha HI; Phelan D; Moazami N; Ewald GA; Mohanakumar T
Transplantation; 2011 May; 91(9):1036-43. PubMed ID: 21383658
[TBL] [Abstract][Full Text] [Related]
3. Donor-specific antibodies to human leukocyte antigens are associated with and precede antibodies to major histocompatibility complex class I-related chain A in antibody-mediated rejection and cardiac allograft vasculopathy after human cardiac transplantation.
Nath DS; Angaswamy N; Basha HI; Phelan D; Moazami N; Ewald GA; Mohanakumar T
Hum Immunol; 2010 Dec; 71(12):1191-6. PubMed ID: 20868717
[TBL] [Abstract][Full Text] [Related]
4. Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts.
Mahesh B; Leong HS; Nair KS; McCormack A; Sarathchandra P; Rose ML
Transplantation; 2010 Jul; 90(1):4-13. PubMed ID: 20463646
[TBL] [Abstract][Full Text] [Related]
5. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
6. Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.
Angaswamy N; Tiriveedhi V; Sarma NJ; Subramanian V; Klein C; Wellen J; Shenoy S; Chapman WC; Mohanakumar T
Hum Immunol; 2013 Nov; 74(11):1478-85. PubMed ID: 23876679
[TBL] [Abstract][Full Text] [Related]
7. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
Frank R; Molina MR; Wald JW; Goldberg LR; Kamoun M; Lal P
J Heart Lung Transplant; 2013 Apr; 32(4):410-7. PubMed ID: 23498162
[TBL] [Abstract][Full Text] [Related]
8. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy.
Yuan X; Paez-Cortez J; Schmitt-Knosalla I; D'Addio F; Mfarrej B; Donnarumma M; Habicht A; Clarkson MR; Iacomini J; Glimcher LH; Sayegh MH; Ansari MJ
J Exp Med; 2008 Dec; 205(13):3133-44. PubMed ID: 19047438
[TBL] [Abstract][Full Text] [Related]
9. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
[TBL] [Abstract][Full Text] [Related]
10. The clinical impact of donor-specific antibodies in heart transplantation.
Barten MJ; Schulz U; Beiras-Fernandez A; Berchtold-Herz M; Boeken U; Garbade J; Hirt S; Richter M; Ruhpawar A; Sandhaus T; Schmitto JD; Schönrath F; Schramm R; Schweiger M; Wilhelm M; Zuckermann A
Transplant Rev (Orlando); 2018 Oct; 32(4):207-217. PubMed ID: 29804793
[TBL] [Abstract][Full Text] [Related]
11. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
[TBL] [Abstract][Full Text] [Related]
12. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
[TBL] [Abstract][Full Text] [Related]
13. Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantation.
See SB; Mantell BS; Clerkin KJ; Ray B; Vasilescu ER; Marboe CC; Naka Y; Restaino S; Colombo PC; Addonizio LJ; Farr MA; Zorn E
Am J Transplant; 2020 Sep; 20(9):2571-2580. PubMed ID: 32190967
[TBL] [Abstract][Full Text] [Related]
14. Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.
Kalache S; Dinavahi R; Pinney S; Mehrotra A; Cunningham MW; Heeger PS
J Immunol; 2011 Jul; 187(2):1023-30. PubMed ID: 21677143
[TBL] [Abstract][Full Text] [Related]
15. Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody.
Hodges AM; Lyster H; McDermott A; Rice AJ; Smith JD; Rose ML; Banner NR
Transplantation; 2012 Mar; 93(6):650-6. PubMed ID: 22245878
[TBL] [Abstract][Full Text] [Related]
16. Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
Saini D; Weber J; Ramachandran S; Phelan D; Tiriveedhi V; Liu M; Steward N; Aloush A; Hachem R; Trulock E; Meyers B; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2011 Jun; 30(6):624-31. PubMed ID: 21414808
[TBL] [Abstract][Full Text] [Related]
17. Association of MICA and AT1R antibodies with antibody-mediated rejection and cardiac allograft vasculopathy in a pediatric heart transplant recipient.
Chou-Wu E; Kemna M; Ross S; Youngs D; Law Y; Gimferrer I
Transpl Immunol; 2023 Jun; 78():101811. PubMed ID: 36889546
[TBL] [Abstract][Full Text] [Related]
18. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
[TBL] [Abstract][Full Text] [Related]
19. Immune function surveillance: association with rejection, infection and cardiac allograft vasculopathy.
Heikal NM; Bader FM; Martins TB; Pavlov IY; Wilson AR; Barakat M; Stehlik J; Kfoury AG; Gilbert EM; Delgado JC; Hill HR
Transplant Proc; 2013; 45(1):376-82. PubMed ID: 23267802
[TBL] [Abstract][Full Text] [Related]
20. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.
Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR
Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
